{"meta":{"query_hash":"4ef87a6913db","filters":{"venue":"Substance Use &amp Addiction Journal"},"cohort_total":15,"direct_labels_cover":0,"predictions_cover":15,"exported":15,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4ef87a6913db","api":"https://metacan.xera.ac/api/v1/cohort?venue=Substance+Use+%26amp+Addiction+Journal"},"results":[{"id":"W4390410674","doi":"10.1177/29767342231208521","title":"Perceptions and Attitudes Related to Driving after Cannabis Use in Canadian and US Adults","year":2023,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Peter Boris Centre for Addictions Research","keywords":"Cannabis; Demography; Psychology; Perception; Cognition; Injury prevention; Poison control; Medicine; Psychiatry; Environmental health","score_opus":0.016946690677457195,"score_gpt":0.2880690611005798,"score_spread":0.2711223704231226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390410674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713767,0.00024265742,0.000028704388,0.00021117776,0.000013033725,0.000019637459,0.00044055367,0.0000022381205,0.0019042275],"genre_scores_gemma":[0.9984674,0.0003079707,0.000087278415,0.00013089078,0.0000067373817,0.000008894896,0.00038565937,0.0000014742981,0.00060368516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992434,0.00004109585,0.000045571895,0.000063636835,0.00040065745,0.00020562255],"domain_scores_gemma":[0.9984359,0.00007771118,0.00036964944,0.00003328089,0.00063223555,0.00045113912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006695176,0.00024925274,0.00031278812,0.0011621973,0.0029509345,0.001163357,0.00044064637,0.0004474792,0.0027938918],"category_scores_gemma":[0.0021587303,0.00020609975,0.0006303798,0.0014397481,0.0008404584,0.00046359748,0.0006650457,0.00088477664,0.00021262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060136055,0.00006330903,0.98720586,0.000030301528,0.0000347714,0.00006030226,0.006641741,0.000034150835,0.00017990572,0.000092949675,0.0006495072,0.004947115],"study_design_scores_gemma":[0.0000030429703,0.000038484457,0.9911062,0.000027122993,0.000014070297,0.00007612449,0.007633226,0.00005723224,0.000032883047,0.000016000078,0.0009837374,0.000011913813],"about_ca_topic_score_codex":0.9720873,"about_ca_topic_score_gemma":0.98241353,"teacher_disagreement_score":0.027912676,"about_ca_system_score_codex":0.007046515,"about_ca_system_score_gemma":0.010174953,"threshold_uncertainty_score":0.056154072},"labels":[],"label_agreement":null},{"id":"W4391144322","doi":"10.1177/29767342231222103","title":"The FASTER-BUP Study, Extended-Release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose: Protocol for an Observational Prospective Study","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"British Columbia Centre on Substance Use; University of British Columbia","funders":"Mitacs; Indivior","keywords":"Buprenorphine; Opioid use disorder; Medicine; Observational study; Opioid overdose; Methadone; Opiate Substitution Treatment; Opioid; Substance abuse; Public health; Fentanyl; Intensive care medicine; Emergency medicine; Psychiatry; Anesthesia; Internal medicine; Nursing; (+)-Naloxone","score_opus":0.05792780422842358,"score_gpt":0.34271183256514054,"score_spread":0.28478402833671695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391144322","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035078228,0.00020286517,0.00084866484,0.00011118639,0.00013007536,0.9920144,0.0024365955,0.00003976192,0.0007087243],"genre_scores_gemma":[0.0023295651,0.00012850751,0.001384845,0.000121802215,0.00003493728,0.9951083,0.00063027476,0.000004821098,0.0002569828],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9910982,0.0042194393,0.0012796567,0.0011991028,0.001184241,0.0010193114],"domain_scores_gemma":[0.99137926,0.00096934376,0.0015916768,0.00093458337,0.0035093534,0.0016157641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02022583,0.004591939,0.006348943,0.0021068468,0.0046114363,0.0029139677,0.002991186,0.0040994114,0.03260903],"category_scores_gemma":[0.012747438,0.0031146486,0.0038411678,0.003218766,0.0025765428,0.002966114,0.0018697653,0.0061546103,0.008859427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69543266,0.106107205,0.022216463,0.019446447,0.00284794,0.0010748766,0.0020344479,0.005467862,0.006931247,0.007981067,0.06731968,0.0631401],"study_design_scores_gemma":[0.7379485,0.09031394,0.052202556,0.0039499113,0.0011578569,0.000286153,0.001297902,0.002988604,0.002213807,0.0039047238,0.103327796,0.00040825945],"about_ca_topic_score_codex":0.010749103,"about_ca_topic_score_gemma":0.0170413,"teacher_disagreement_score":0.03260903,"about_ca_system_score_codex":0.007328021,"about_ca_system_score_gemma":0.022745669,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4393159021","doi":"10.1177/29767342241237169","title":"Perspectives of Canadian Healthcare and Harm Reduction Workers on Mobile Overdose Response Services: A Qualitative Study","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Harm reduction; Health care; Harm; Thematic analysis; Medicine; Qualitative research; Nursing; Medical emergency; Psychology; Public health; Sociology; Political science; Social psychology","score_opus":0.03611189377055793,"score_gpt":0.35532605601691114,"score_spread":0.31921416224635324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393159021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645473,0.001850045,0.0013138003,0.0127935745,0.00021955869,0.00068280945,0.0005532624,0.00003618639,0.01800342],"genre_scores_gemma":[0.98259497,0.0021789393,0.0013464951,0.0053358623,0.00004136655,0.0004910716,0.00016858419,0.000046463203,0.007796243],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98955566,0.0039006835,0.00027055043,0.0006323332,0.0014586106,0.0041821427],"domain_scores_gemma":[0.9845412,0.006735573,0.00089173665,0.00024772115,0.0036025362,0.0039811446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00897571,0.0008377622,0.0011412074,0.003043775,0.037046954,0.0071773916,0.0026738185,0.0030311116,0.00505549],"category_scores_gemma":[0.014987015,0.0008085535,0.0005837309,0.0056665516,0.013851066,0.0026500558,0.0063702976,0.004614835,0.00043672303],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026645119,0.000028811039,0.0025106524,0.00014139157,0.0000024124843,0.0007553346,0.99100095,0.000021217646,0.00041849076,0.00069086906,0.0011818063,0.003221469],"study_design_scores_gemma":[0.0000021817532,0.000011910419,0.0010716986,0.00012495095,0.0000020236696,0.000054010477,0.9910563,0.000026731594,0.00005418806,0.00005050372,0.007535766,0.000009787335],"about_ca_topic_score_codex":0.90548134,"about_ca_topic_score_gemma":0.93004006,"teacher_disagreement_score":0.09451866,"about_ca_system_score_codex":0.08492372,"about_ca_system_score_gemma":0.10741568,"threshold_uncertainty_score":0.6161676},"labels":[],"label_agreement":null},{"id":"W4397021752","doi":"10.1177/29767342241248926","title":"Electronic-Screening, Brief Intervention and Referral to Treatment (e-SBIRT) for Addictive Disorders: Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Substance Use &amp Addiction Journal","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gambling Research Exchange Ontario","keywords":"Brief intervention; Medicine; PsycINFO; Addiction; Psychological intervention; MEDLINE; Meta-analysis; Abstinence; Psychiatry; Family medicine; Internal medicine","score_opus":0.13485909616115138,"score_gpt":0.39247442245506436,"score_spread":0.257615326293913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397021752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026865245,0.9948631,0.000543865,0.00019595047,0.00011964113,0.00077000866,0.0005062899,0.000031314725,0.0002832528],"genre_scores_gemma":[0.06852753,0.9234057,0.003221968,0.0009812663,0.00017186458,0.002673423,0.000725013,0.000026760437,0.00026642246],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.987756,0.0056148483,0.0038226563,0.00093206187,0.001504631,0.00036982726],"domain_scores_gemma":[0.9720229,0.021110998,0.0040827813,0.0006719005,0.0018146643,0.00029664094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01871593,0.002836817,0.018126626,0.008140956,0.0007888422,0.0032680985,0.0026059428,0.002482089,0.0052918126],"category_scores_gemma":[0.046844702,0.0013467061,0.036044747,0.008978188,0.0008036458,0.0026143354,0.0019934988,0.0020273612,0.00036313853],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014059641,0.00006290302,0.0014723007,0.7314192,0.24427044,0.00006163884,0.000081424674,0.0003049731,0.00011995987,0.00012081542,0.00055551995,0.020124868],"study_design_scores_gemma":[0.00089959736,0.0004075888,0.0030431189,0.101815134,0.89096904,0.00008825585,0.00006941149,0.00017065222,0.0001624962,0.00020346165,0.0021426652,0.000028594884],"about_ca_topic_score_codex":0.009484503,"about_ca_topic_score_gemma":0.01975134,"teacher_disagreement_score":0.01871593,"about_ca_system_score_codex":0.004175549,"about_ca_system_score_gemma":0.0075651165,"threshold_uncertainty_score":0.09898049},"labels":[],"label_agreement":null},{"id":"W4399083984","doi":"10.1177/29767342241249870","title":"Characterizing the Use of Healthcare Access Supports Among People Who Use Drugs in Vancouver, Canada, 2017 to 2020: A Cohort Study","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Providence Health Care; British Columbia Centre on Substance Use; Simon Fraser University","funders":"National Institutes of Health; Michael Smith Health Research BC; National Institute on Drug Abuse; St. Paul's Foundation; Canadian Institutes of Health Research; Canadian Foundation for AIDS Research","keywords":"Outreach; Health care; Medicine; Cohort; Family medicine; Health professionals; Nursing; Gerontology; Political science","score_opus":0.05842455161725457,"score_gpt":0.3223696570986987,"score_spread":0.2639451054814441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399083984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98294246,0.0010199065,0.00025046148,0.00031063694,0.000028694705,0.00023575152,0.013581173,0.000011257387,0.0016196091],"genre_scores_gemma":[0.99005365,0.0010310195,0.00056197325,0.00024233338,0.000013776298,0.00022710103,0.0065378686,0.0000105560985,0.0013216811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998741,0.00011463621,0.00011551582,0.0002485499,0.00035627387,0.00042419063],"domain_scores_gemma":[0.99708706,0.00011656703,0.0004728483,0.00015784717,0.0014695781,0.00069613097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012634667,0.0005290363,0.00060697895,0.0020311717,0.0042088055,0.002207332,0.0018869432,0.00071270234,0.0017474149],"category_scores_gemma":[0.0027556457,0.0007297168,0.0010069252,0.004573782,0.0007552944,0.00062024704,0.0018969,0.0014983075,0.0003801517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041121424,0.000032270666,0.99647635,0.00004166603,0.00006583755,0.000047210917,0.0007099882,0.000030737196,0.000051552295,0.000032864995,0.00081737846,0.0016530501],"study_design_scores_gemma":[0.000010799713,0.000029884242,0.99579394,0.00009653083,0.00005042545,0.000060992228,0.002688155,0.00017626114,0.000032079493,0.000024530375,0.0010239795,0.000012385144],"about_ca_topic_score_codex":0.9813756,"about_ca_topic_score_gemma":0.990031,"teacher_disagreement_score":0.018624425,"about_ca_system_score_codex":0.013551602,"about_ca_system_score_gemma":0.019920561,"threshold_uncertainty_score":0.09832418},"labels":[],"label_agreement":null},{"id":"W4401157995","doi":"10.1177/29767342241258915","title":"Co-Design of a Digital Health Tool for Use by Individuals With Opioid Use Disorder: App4Independence (A4i-O)","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Scarborough Hospital; Apotex (Canada); University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Opioid use disorder; Opioid; Psychology; Medicine; Internal medicine","score_opus":0.03140892993692366,"score_gpt":0.2957493080792733,"score_spread":0.2643403781423496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401157995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59178585,0.0010072199,0.2898977,0.007557695,0.0013517088,0.053374317,0.0015870898,0.0038202438,0.049618147],"genre_scores_gemma":[0.37793574,0.0006756777,0.54916996,0.0017457234,0.00013700151,0.05706368,0.0006819324,0.00037369714,0.012216607],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.98998255,0.00772551,0.00045869203,0.0007049212,0.0006025481,0.0005257538],"domain_scores_gemma":[0.9832199,0.011687152,0.0006671327,0.0014804474,0.0013716262,0.0015737255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014556763,0.0009638765,0.00047594868,0.0012134,0.0021208439,0.0028908262,0.0017984573,0.0013682559,0.0116369855],"category_scores_gemma":[0.03039799,0.00048232122,0.0011766792,0.000523062,0.0021760913,0.0029029604,0.0061418223,0.0015760867,0.0020063098],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031410134,0.007850461,0.014517063,0.010570112,0.00015241497,0.0019667416,0.15637779,0.0021495281,0.014608191,0.0157157,0.028166862,0.7447841],"study_design_scores_gemma":[0.0055408147,0.021009233,0.027131135,0.007876505,0.0009878654,0.0027448754,0.1849129,0.013224159,0.029894248,0.046384804,0.65969783,0.00059557526],"about_ca_topic_score_codex":0.00047976416,"about_ca_topic_score_gemma":0.001187052,"teacher_disagreement_score":0.014556763,"about_ca_system_score_codex":0.0010964067,"about_ca_system_score_gemma":0.00416093,"threshold_uncertainty_score":0.076984465},"labels":[],"label_agreement":null},{"id":"W4401793989","doi":"10.1177/29767342241266412","title":"“SafetyNet”: Evaluation of a Recovery Coach and Paramedic Intervention Following Naloxone Resuscitation From an Opioid Overdose","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Centers for Disease Control and Prevention","keywords":"Opioid overdose; (+)-Naloxone; Resuscitation; Medicine; Opioid; Anesthesia; Intervention (counseling); Medical emergency; Emergency medicine; Nursing; Internal medicine","score_opus":0.04159831796547188,"score_gpt":0.34107720776647193,"score_spread":0.29947888980100007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401793989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964181,0.00009189426,0.00025456023,0.00016088817,0.000023763529,0.0023565572,0.000050074283,0.000033367225,0.0006107439],"genre_scores_gemma":[0.9871394,0.0004775094,0.0050167292,0.0002808536,0.00006668078,0.005712723,0.00020672833,0.000007603903,0.0010917755],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988103,0.0006862918,0.000087724875,0.00011818234,0.00014175187,0.00015573906],"domain_scores_gemma":[0.9986791,0.00027241957,0.00027569386,0.0000615557,0.00015682893,0.00055439136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013890894,0.00061638205,0.00044116296,0.000313363,0.00059330935,0.00040727816,0.001033268,0.0007756341,0.005216621],"category_scores_gemma":[0.0028475488,0.00030971423,0.000724126,0.00014144776,0.00037945618,0.0006576972,0.0008805681,0.0009470861,0.00031127987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116031714,0.47153485,0.026330275,0.0023654099,0.0006759298,0.00040767554,0.0016983494,0.0035215628,0.00800872,0.00034342575,0.0018622743,0.36721978],"study_design_scores_gemma":[0.069352545,0.86588675,0.053474594,0.00027407505,0.0003444057,0.00016927466,0.0009397443,0.0033542977,0.003290838,0.00014192381,0.0027296906,0.000041763382],"about_ca_topic_score_codex":0.0021844015,"about_ca_topic_score_gemma":0.005109098,"teacher_disagreement_score":0.005216621,"about_ca_system_score_codex":0.0010344702,"about_ca_system_score_gemma":0.0036157214,"threshold_uncertainty_score":0.017451346},"labels":[],"label_agreement":null},{"id":"W4403380249","doi":"10.1177/29767342241279167","title":"Redesigning a Stopped Clinical Trial as an Emulated Trial Using Real-World Data to Explore the Effectiveness of Slow-Release Oral Morphine as a Treatment for Opioid Use Disorder","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"British Columbia Centre on Substance Use; University of British Columbia","funders":"Canadian Institutes of Health Research; Vancouver Foundation","keywords":"Randomized controlled trial; Opioid use disorder; Clinical trial; Pandemic; Psychological intervention; Population; Medicine; Timeline; Opioid overdose; Psychiatry; Psychology; Coronavirus disease 2019 (COVID-19); Opioid; Surgery; Environmental health","score_opus":0.31587762677957515,"score_gpt":0.4606705425442611,"score_spread":0.14479291576468595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403380249","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041644294,0.059971664,0.09924388,0.6114799,0.17848846,0.022886908,0.0019781783,0.0010499717,0.02073663],"genre_scores_gemma":[0.051952653,0.024603125,0.18989126,0.6273239,0.046245437,0.05014966,0.0007180624,0.00062531116,0.008490529],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.37311807,0.5481331,0.036498543,0.010360339,0.029714633,0.0021752361],"domain_scores_gemma":[0.19112895,0.7205403,0.022371557,0.025554284,0.036113564,0.004291342],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.44051144,0.001697097,0.0038372818,0.0031778384,0.0036178057,0.012397345,0.0071663707,0.023979293,0.007010345],"category_scores_gemma":[0.70578367,0.0015299778,0.008408639,0.0029924903,0.012903755,0.012616653,0.0061676037,0.024746649,0.0024747353],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009353235,0.0004623125,0.002290624,0.048637602,0.0057252464,0.00065838045,0.0069480967,0.0032710521,0.0011024141,0.21625668,0.3667602,0.33853418],"study_design_scores_gemma":[0.011914543,0.003344907,0.0017118069,0.07304214,0.0051573957,0.00030854688,0.0013408362,0.0040056817,0.0018173286,0.13416184,0.76269156,0.0005034522],"about_ca_topic_score_codex":0.004789402,"about_ca_topic_score_gemma":0.009629527,"teacher_disagreement_score":0.44051144,"about_ca_system_score_codex":0.012153396,"about_ca_system_score_gemma":0.037958898,"threshold_uncertainty_score":0.68994904},"labels":[],"label_agreement":null},{"id":"W4404889388","doi":"10.1177/29767342241298044","title":"Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada","year":2024,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Waypoint Centre for Mental Health Care; University of Toronto; Centre for Addiction and Mental Health; Université de Montréal; British Columbia Centre on Substance Use; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Canadian Institutes of Health Research; Mitacs","keywords":"Buprenorphine; Methadone; Methamphetamine; Amphetamine; (+)-Naloxone; Opioid use disorder; Psychiatry; Medicine; Opioid; Psychology; Internal medicine; Dopamine","score_opus":0.018386105647508692,"score_gpt":0.25762120373275976,"score_spread":0.23923509808525106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404889388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950876,0.013392164,0.00014506879,0.0009801781,0.00004658946,0.0007231993,0.0019135562,0.000012387233,0.0032781092],"genre_scores_gemma":[0.9948626,0.0031713296,0.0004684066,0.00033486268,0.000019034638,0.00013893135,0.00057891326,0.0000036552808,0.0004223182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960341,0.0011621712,0.00032189305,0.00027581144,0.0014660491,0.000740036],"domain_scores_gemma":[0.99500173,0.0007288614,0.0011515585,0.00009005195,0.0014788855,0.0015489782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025980475,0.000328207,0.0010575,0.0006569273,0.0013318324,0.00094594795,0.0010069655,0.00061573734,0.001737442],"category_scores_gemma":[0.008784812,0.0002968348,0.0015923408,0.0016620829,0.00077685725,0.00031940907,0.0008463778,0.0008059888,0.00005757254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08465269,0.0041583516,0.62174815,0.008606479,0.0097776735,0.00031841043,0.0027541756,0.0046594297,0.0028570762,0.0015368473,0.006559288,0.25237146],"study_design_scores_gemma":[0.010990052,0.010256581,0.96230423,0.0012889405,0.005324636,0.00017137476,0.0018276148,0.0025882113,0.0007855007,0.00019947371,0.004165295,0.00009805017],"about_ca_topic_score_codex":0.9717551,"about_ca_topic_score_gemma":0.9890778,"teacher_disagreement_score":0.04810189,"about_ca_system_score_codex":0.04810189,"about_ca_system_score_gemma":0.06174844,"threshold_uncertainty_score":0.34900522},"labels":[],"label_agreement":null},{"id":"W4407226119","doi":"10.1177/29767342251313595","title":"Substance Use Disorder and Harm Reduction Curriculum in United States and Canadian Undergraduate Medical Education: An Online Survey","year":2025,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Drug Abuse","keywords":"Harm reduction; Medicine; Methadone; Opioid use disorder; Family medicine; Buprenorphine; Curriculum; Heroin; Substance abuse; Addiction; Psychiatry; Public health; Opioid; Psychology; Nursing; Drug","score_opus":0.030041256456929573,"score_gpt":0.3070661678603488,"score_spread":0.2770249114034192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407226119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899283,0.0003011727,0.000054210537,0.0010124298,0.00001619605,0.00017188374,0.0055209887,0.000017338052,0.002977484],"genre_scores_gemma":[0.99279916,0.0008074197,0.0004729606,0.0007432406,0.000018946308,0.0001102635,0.0031509425,0.0000075217595,0.0018896443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982381,0.00012992907,0.00016681186,0.00014557835,0.00085307256,0.00046643795],"domain_scores_gemma":[0.9934977,0.0003643785,0.0016228645,0.00008563438,0.0021716119,0.0022576884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016605083,0.00024036608,0.00027520378,0.0017977648,0.001823209,0.0009933757,0.00079643656,0.0005430073,0.0026638717],"category_scores_gemma":[0.004925141,0.00033293484,0.00034068534,0.0029976661,0.00052077783,0.0004766431,0.001008466,0.0007265505,0.00044742695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038061968,0.00017408872,0.98514396,0.000073958785,0.000016874279,0.000031000935,0.0018519547,0.000034058874,0.00014809718,0.000034667653,0.0033720764,0.009081103],"study_design_scores_gemma":[0.000004822104,0.000033543012,0.99563783,0.00002779172,0.000005264924,0.0000188326,0.0021327324,0.000075354474,0.000046783705,0.0000042847187,0.0020069312,0.0000059228273],"about_ca_topic_score_codex":0.8955641,"about_ca_topic_score_gemma":0.94789594,"teacher_disagreement_score":0.9878961,"about_ca_system_score_codex":0.0121038975,"about_ca_system_score_gemma":0.019573499,"threshold_uncertainty_score":0.2101019},"labels":[],"label_agreement":null},{"id":"W4410097107","doi":"10.1177/29767342251326374","title":"The Unsolved Problem of Attrition Rates on Randomized Clinical Trials for Cocaine Use Disorders: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Substance Use &amp Addiction Journal","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute on Drug Abuse","keywords":"Attrition; Randomized controlled trial; Medicine; Selection bias; Cocaine use; Psychiatry; Surgery","score_opus":0.3565707453020253,"score_gpt":0.5116996126184731,"score_spread":0.15512886731644776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410097107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016918683,0.94194514,0.019614372,0.024969058,0.003581038,0.004070153,0.0011285008,0.00019350399,0.0028064495],"genre_scores_gemma":[0.061116457,0.8216779,0.061324432,0.02379303,0.003365929,0.025964877,0.001327272,0.0003666126,0.0010634005],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.4116802,0.35764685,0.15632086,0.013877163,0.0579156,0.0025593766],"domain_scores_gemma":[0.08542672,0.83746284,0.034998678,0.014494124,0.026815921,0.00080173573],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.530701,0.002919605,0.015764372,0.019938314,0.0030707184,0.0116298245,0.007994338,0.009518803,0.004733432],"category_scores_gemma":[0.7998427,0.0045699165,0.012914521,0.017826024,0.008576321,0.016488701,0.007745771,0.008572361,0.001471425],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005053149,0.000076107804,0.0029223987,0.6287455,0.017574403,0.00021415652,0.0024938588,0.000993861,0.00028493692,0.016681734,0.017051607,0.31245613],"study_design_scores_gemma":[0.00036766654,0.00024974285,0.0025942686,0.901047,0.020033529,0.00031801808,0.000755304,0.0010918702,0.00049105467,0.021797927,0.05112739,0.00012616247],"about_ca_topic_score_codex":0.0063877604,"about_ca_topic_score_gemma":0.009618841,"teacher_disagreement_score":0.46929902,"about_ca_system_score_codex":0.0142796645,"about_ca_system_score_gemma":0.04328515,"threshold_uncertainty_score":0.5787293},"labels":[],"label_agreement":null},{"id":"W4412675784","doi":"10.1177/29767342251351123","title":"Psychedelics for the Treatment of Substance Use Disorders: A Narrative Review of the Literature","year":2025,"lang":"en","type":"review","venue":"Substance Use &amp Addiction Journal","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Generalizability theory; Observational study; Psychology; Population; Clinical trial; Clinical psychology; Psychotherapist; Psychiatry; Medicine; Developmental psychology","score_opus":0.09561556191326293,"score_gpt":0.40578907666113,"score_spread":0.3101735147478671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412675784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016681245,0.99887675,0.000051471827,0.00041105266,0.00011580343,0.000030261697,0.000041607454,0.000002391037,0.0003038705],"genre_scores_gemma":[0.0020572464,0.99676776,0.00022514469,0.00059886475,0.00015308429,0.00006428671,0.000040870524,0.0000014634176,0.000091311995],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975115,0.0010197618,0.0007839961,0.00018681448,0.0004097989,0.000088104396],"domain_scores_gemma":[0.9912322,0.006397489,0.0014800878,0.00009381136,0.0006661945,0.00013009508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034641954,0.0011268401,0.0017594016,0.0057681305,0.00067247904,0.0020742055,0.0010775169,0.00160177,0.0036495326],"category_scores_gemma":[0.012470958,0.00040848678,0.001979975,0.0044772956,0.0007098534,0.0018462824,0.0011295123,0.0013736064,0.00045760808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026261827,0.00005927867,0.00054647034,0.6012686,0.0010464085,0.00057295716,0.0009856636,0.00019684286,0.00043575958,0.0030545243,0.018617207,0.37295374],"study_design_scores_gemma":[0.00008807012,0.00021845428,0.002225872,0.7514096,0.004329256,0.0020921659,0.00092668,0.00010435511,0.00023989122,0.0016129722,0.23670818,0.000044595257],"about_ca_topic_score_codex":0.0024495719,"about_ca_topic_score_gemma":0.007295612,"teacher_disagreement_score":0.0057681305,"about_ca_system_score_codex":0.0015385711,"about_ca_system_score_gemma":0.007056765,"threshold_uncertainty_score":0.01832062},"labels":[],"label_agreement":null},{"id":"W4412739890","doi":"10.1177/29767342251356352","title":"Risk Perceptions Related to Driving After Use of Alcohol and Cannabis in a Cross-National Sample of University Students in 6 Countries","year":2025,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universitat Jaume I; National Institute on Alcohol Abuse and Alcoholism; Ministerio de Ciencia, Innovación y Universidades; Secretaría de Educación Superior, Ciencia, Tecnología e Innovación; Universidad Nacional de Córdoba","keywords":"Cannabis; Driving under the influence; Risk perception; Injury prevention; Human factors and ergonomics; Poison control; Suicide prevention; Perception; Enforcement; Environmental health; Medicine; Psychology; Demography; Psychiatry; Political science","score_opus":0.020737539549464428,"score_gpt":0.31194499582808805,"score_spread":0.2912074562786236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412739890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997162,0.000035692472,0.0000110839665,0.000011053164,0.0000018926223,0.000007156585,0.00006698361,3.9711117e-7,0.00014946354],"genre_scores_gemma":[0.99957615,0.00006994555,0.000034455654,0.000022505681,0.0000019743627,0.000011491423,0.00015013214,7.149964e-7,0.00013259011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954706,0.00010697771,0.00005866878,0.00007804244,0.00008992614,0.00011933121],"domain_scores_gemma":[0.99837106,0.00017727651,0.00065910205,0.00007734363,0.00032135824,0.00039393804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091746385,0.00027284987,0.00040451717,0.0010695328,0.0009492206,0.0010947791,0.00029310668,0.0004955159,0.0016219197],"category_scores_gemma":[0.0022236947,0.00036976565,0.00043864793,0.0010078734,0.00047297816,0.0004909421,0.0008682362,0.00055112905,0.00030905823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038337843,0.00008198637,0.9971517,0.000012469869,0.000020125855,0.000032354154,0.0014814861,0.0000137602365,0.00010182984,0.000009763212,0.000057244608,0.0009990372],"study_design_scores_gemma":[0.0000029790654,0.000076328804,0.9954585,0.000012458516,0.000008343514,0.00004848086,0.0041584787,0.000039310715,0.000035539342,0.000004930567,0.0001512145,0.000003461694],"about_ca_topic_score_codex":0.048892576,"about_ca_topic_score_gemma":0.0604998,"teacher_disagreement_score":0.048892576,"about_ca_system_score_codex":0.0006410323,"about_ca_system_score_gemma":0.00056924287,"threshold_uncertainty_score":0.09721601},"labels":[],"label_agreement":null},{"id":"W4415383408","doi":"10.1177/29767342251370454","title":"Substance Use During the COVID-19 Pandemic in the Americas: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Substance use; Pandemic; Mental health; Public health; Coronavirus disease 2019 (COVID-19); Vulnerability (computing); Substance abuse; Health care","score_opus":0.12112936040771097,"score_gpt":0.4025708137875496,"score_spread":0.2814414533798386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415383408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005647042,0.99815446,0.00005908445,0.0003728573,0.00014297735,0.00007506198,0.00015083888,0.0000035767475,0.00047632263],"genre_scores_gemma":[0.0035082614,0.9958203,0.00014256821,0.00024283097,0.000056881305,0.000084748695,0.00009350609,0.000001707078,0.00004911647],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99650025,0.000901576,0.0014686453,0.00028103165,0.00068151235,0.0001670145],"domain_scores_gemma":[0.9744888,0.019933607,0.0029412461,0.00024052347,0.0021388934,0.0002568827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055142925,0.0009986616,0.0028228103,0.014842144,0.0011213671,0.0034438334,0.0013369361,0.0025668754,0.0026965176],"category_scores_gemma":[0.02614156,0.0008300854,0.0036877147,0.015614187,0.0010324818,0.0025554858,0.001815082,0.0012589805,0.00029427625],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075806114,0.00003091698,0.0020597556,0.8396241,0.001833241,0.0002513994,0.0011140753,0.00019340942,0.00016116514,0.00089446607,0.0059760283,0.14778563],"study_design_scores_gemma":[0.000012779897,0.00005599406,0.004362525,0.94688046,0.004767615,0.00040322068,0.0010265373,0.000063821164,0.00009794236,0.00034154023,0.04196572,0.000021895554],"about_ca_topic_score_codex":0.021022892,"about_ca_topic_score_gemma":0.03777291,"teacher_disagreement_score":0.021022892,"about_ca_system_score_codex":0.0034947696,"about_ca_system_score_gemma":0.01777974,"threshold_uncertainty_score":0.041801035},"labels":[],"label_agreement":null},{"id":"W4416817547","doi":"10.1177/29767342251392342","title":"Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations","year":2025,"lang":"en","type":"article","venue":"Substance Use &amp Addiction Journal","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Drug Abuse; National Institute of Mental Health","keywords":"Buprenorphine; Public health; Mainstream; Health care; Health policy; Public policy","score_opus":0.03263982404004371,"score_gpt":0.3699714243432664,"score_spread":0.3373316003032227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416817547","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016718096,0.37997985,0.0015524313,0.60415614,0.0034698627,0.00007558025,0.0005665265,0.000107790416,0.008419978],"genre_scores_gemma":[0.04745569,0.81930804,0.012093007,0.11307643,0.003028466,0.0003973703,0.0006996196,0.00006029852,0.00388114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681,0.001487521,0.00027375578,0.00035151778,0.0005166228,0.0005604562],"domain_scores_gemma":[0.984736,0.008436382,0.0010209983,0.0003387867,0.0037922973,0.0016755083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009372792,0.0014349007,0.0017665614,0.0033420809,0.0013940246,0.006545098,0.0027976087,0.0069395946,0.014131984],"category_scores_gemma":[0.01641989,0.0005146808,0.0021378817,0.0036524362,0.0025616079,0.009769662,0.003983159,0.00821667,0.0016716485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022236351,0.00033733927,0.00557087,0.028020483,0.00062470115,0.00062600366,0.0037280736,0.0030527127,0.0007202393,0.11296697,0.3687011,0.4754292],"study_design_scores_gemma":[0.00010930874,0.00014143632,0.005255308,0.06821676,0.00066085334,0.0002750229,0.011915235,0.0011125477,0.00039428816,0.087552585,0.8242565,0.000110128865],"about_ca_topic_score_codex":0.019684225,"about_ca_topic_score_gemma":0.031351477,"teacher_disagreement_score":0.019684225,"about_ca_system_score_codex":0.00511897,"about_ca_system_score_gemma":0.029582378,"threshold_uncertainty_score":0.049568594},"labels":[],"label_agreement":null}]}